VILNIAUS MEDICINOS SERVISAS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,475,570 | 2,211,380 | 1,869,931 | 2,410,385 | 2,510,177 | 2,757,844 | 2,773,108 | 3,057,657 |
| Profit before tax | 156,328 | 221,525 | 279,858 | 409,267 | 265,051 | 272,932 | 244,362 | 244,594 |
| Net profit | 132,355 | 187,702 | 237,627 | 347,472 | 224,938 | 232,819 | 207,302 | 202,277 |
| Equity | 627,048 | 814,750 | 952,376 | 1,099,848 | 774,786 | 1,007,605 | 1,215,169 | 1,167,446 |
| Liabilities | 283,128 | 463,671 | 483,088 | 453,424 | 833,809 | 855,134 | 544,359 | 579,949 |
| Non-current assets | 166,164 | 162,512 | 280,710 | 277,346 | 247,041 | 454,151 | 508,136 | 328,985 |
| Current assets | 744,012 | 1,115,909 | 1,151,341 | 1,274,909 | 1,357,057 | 1,403,871 | 1,243,885 | 1,413,424 |
| Total assets | 910,176 | 1,278,421 | 1,432,051 | 1,552,255 | 1,604,098 | 1,858,022 | 1,752,021 | 1,742,409 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 481,676 | 484,358 | 555,253 |
| Social insurance contributions | - | - | - | - | - | 45,722 | 52,748 | 63,499 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +24.5% | +49.9% | -15.4% | +28.9% | +4.1% | +9.9% | +0.6% | +10.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 14.5% | 14.7% | 16.6% | 22.4% | 14.0% | 12.5% | 11.8% | 11.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 21.1% | 23.0% | 25.0% | 31.6% | 29.0% | 23.1% | 17.1% | 17.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 9.0% | 8.5% | 12.7% | 14.4% | 9.0% | 8.4% | 7.5% | 6.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 10.6% | 10.0% | 15.0% | 17.0% | 10.6% | 9.9% | 8.8% | 8.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.5 | 0.6 | 0.5 | 0.4 | 1.1 | 0.8 | 0.4 | 0.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 203,527 | 248,004 | 164,994 | 185,414 | 193,091 | 216,301 | 216,087 | 233,707 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
VILNIAUS MEDICINOS SERVISAS - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-04-16 | 2024-05-01 | 25.55 |
| 2023-11-16 | 2023-11-28 | 9.10 |
| 2023-09-18 | 2023-10-01 | 9.31 |
| 2023-07-28 | 2023-07-31 | 9.45 |
| 2023-07-24 | 2023-07-25 | 9.80 |
| 2023-05-16 | 2023-05-24 | 3548.16 |
VILNIAUS MEDICINOS SERVISAS - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-05-01 | 2026-05-03 | 562.44 |
| 2026-04-30 | 2026-04-30 | 559.83 |
| 2026-04-17 | 2026-04-20 | 29.31 |
| 2026-04-15 | 2026-04-16 | 3888.31 |
| 2026-04-06 | 2026-04-14 | 3858.39 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
VILNIAUS MEDICINOS SERVISAS, UAB, a Private Limited Liability Company registered under code 123070311, operates in the wholesale of pharmaceutical and medical goods. In the latest financial year 2025, revenue increased to €3.06M, up 10.3% year on year and 10.9% over two years. Net profit was €202.3K, with a profit margin of 6.6%. The company remained profitable throughout the period, although net profit eased from €232.8K in 2023 to €207.3K in 2024 and €202.3K in 2025, while revenue rose gradually from €2.76M to €2.77M and then to €3.06M. At year-end 2025, total assets stood at €1.74M, equity at €1.17M and liabilities at €579.9K. The equity ratio was 67.0% and debt-to-equity 0.50, indicating a relatively conservative balance sheet. Asset turnover was 1.75x, ROE 17.3% and ROA 11.6%. Revenue per employee reached €235.2K and profit per employee €15.6K.